Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
A Phase 2 double-blind, randomized, placebo-controlled study to evaluate resmetirom in 2 cohorts of subjects with moderate to advanced fibrosis, consistent with stage F2 and F3 fibrosis, who have undergone liver transplant. Cohort 1 will consist of patients who have undergone liver transplant for MASH cirrhosis who developed recurrent MASH. Cohort 2 will consist of subjects who have undergone liver transplant for indications other than MASH cirrhosis who developed de novo MASH.
Epistemonikos ID: 428d15073dec796a80bd8959a3ff2b816cdd1ade
First added on: Jan 14, 2026